Gilead Sciences, Inc.
About Gilead Sciences, Inc.
Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.
2256 articles about Gilead Sciences, Inc.
-
The Medicines Patent Pool And Gilead Expand Licence To Allow Generic Manufacture Of Medicines In South Africa
6/11/2015
-
Receptos Allegedly Rebuffs AstraZeneca PLC Bid But Rivals Gilead, Teva are Circling
6/11/2015
-
Gilead To Present At Two Upcoming Investor Conferences On Tuesday, June 9
6/9/2015
-
Express Scripts Exec's Elaborate Scheme to Load Up a Cruise Ship in India With Cheap Versions of Gilead Sovaldi
6/4/2015
-
Gilead Release: Zydelig In Combination With Ofatumumab Improves Progression-Free Survival In Previously-Treated Patients With Chronic Lymphocytic Leukemia
6/1/2015
-
Gilead’s Hep B Trial Failure Will Inspire M&A Activity, Say Analysts
5/29/2015
-
Gilead Will Hire Up to 170 Scientists in $100 Million Edmonton Expansion
5/29/2015
-
Gilead To Present At The Bernstein 31st Annual Strategic Decisions Conference On Thursday, May 28
5/28/2015
-
European Medicines Agency Validates Gilead’s Marketing Application For Fixed-Dose Combination Of Emtricitabine And Tenofovir Alafenamide For HIV Treatment
5/28/2015
-
Gilead, GlobeImmune's Hep B Drug Flunks Phase II Study
5/27/2015
-
Gilead CFO Says Reliance On Outsourcing Helped It Bump Eli Lilly Out of Top 10 Ranking
5/26/2015
-
As Market Roars, Gilead Looking for "Value-Added" Deals, Says CFO
5/22/2015
-
Achillion, Johnson & Johnson Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead and AbbVie
5/21/2015
-
Twitter Attempts to Marry Gilead, Achillion, Finds Reality Instead
5/20/2015
-
I-MAK Release: Patent Challenges In Five Countries Dispute Validity Of Gilead's Claims To Hep C Drug Patents That Block Treatment For Up To 59 Million People
5/20/2015
-
Gilead To Present At The UBS 2015 Global Healthcare Conference On Tuesday, May 19
5/19/2015
-
Here's Why Gilead Should Avoid Bigger Deals and Focus on Smaller Cancer-Focused Buyouts
5/18/2015
-
Gilead To Present At The Bank of America Merrill Lynch 2015 Health Care Conference On Wednesday, May 13
5/13/2015
-
Forget Gilead - This Tiny Biotech Offers A Much Richer Opportunity
5/12/2015
-
Gilead Finally Spends Some Money With $65 Million Buy
5/8/2015